Edit
Fluidx Medical Technology, Inc.
https://www.fluidxmedical.com/Last activity: 21.05.2024
Active
The GPX and IMPASS Embolic Device platforms are under development and do not have marketing clearance or approval in any market at this time.
Location: United States, Utah, Salt Lake City
Employees: 11-50
Investors 1
| Date | Name | Website |
| - | MedMountai... | mmv.vc |
Mentions in press and media 2
| Date | Title | Description |
| 21.05.2024 | New Embolic Device for Tumor Treatment and Other Oncology Uses Given Nod by FDA to Start Pivotal Clinical Trial | Post-embolization angiogram of the GPX Embolic Device filling a pelvic tumor (as featured on the cover of Journal of Vascular and Interventional Radiology, February 2024) Investigators look forward to evaluating the new device designed for ... |
| 23.04.2021 | Christopher Phillips Named Chair of the BioUtah Regulatory, Compliance and Quality Committee | BioUtah today announced that Christopher Phillips, director of regulatory affairs and clinical affairs at Fluidx Medical Technology, has been appointed chair of BioUtah’s Regulatory, Compliance and Quality Committee. Phillips takes the rein... |